From Wikipedia, the free encyclopedia
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Chimeric ( mouse/ human) |
| Target | VAP-1 |
| Clinical data | |
| ATC code |
|
| Identifiers | |
| CAS Number | |
| ChemSpider |
|
| UNII | |
 N Y
(what is this?)
(verify) | |
Vapaliximab is a chimeric monoclonal antibody [1] and an experimental immunosuppressive drug.[ citation needed] Development was discontinued by 2012. [2]
References
- ^ WHO Drug Information
- ^ "Vapaliximab - AdisInsight". adisinsight.springer.com. Retrieved 2 January 2019.
| Intracellular (initiation) |
| ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (reception) |
| ||||||||||||||
| Extracellular |
| ||||||||||||||
| Unsorted |
| ||||||||||||||
 | This monoclonal antibody–related article is a stub. You can help Wikipedia by expanding it. |
 | This antineoplastic or immunomodulatory drug article is a stub. You can help Wikipedia by expanding it. |
Retrieved from "
https://en.wikipedia.org/?title=Vapaliximab&oldid=1059877507"
Hidden categories:
- Articles with changed CASNo identifier
- Chemicals that do not have a ChemSpider ID assigned
- Articles without EBI source
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Drugs with no legal status
- Drugboxes which contain changes to verified fields
- Drugs that are a monoclonal antibody
- All articles with unsourced statements
- Articles with unsourced statements from October 2009
- All stub articles